Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals Inc (NQ: ADIL )

1.920 USD -0.140 (-6.80%)
Official Closing Price Updated: 7:38 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 329,200
Open 2.070
Bid (Size) 1.930 (2)
Ask (Size) 1.960 (6)
Prev. Close 2.060
Today's Range 1.910 - 2.100
52wk Range 1.000 - 4.000
Shares Outstanding 5,474,856
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
From ACCESSWIRE
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
From ACCESSWIRE

Performance

YTD
+10.98%
+10.98%
1 Month
+2.13%
+2.13%
3 Month
+7.26%
+7.26%
6 Month
+35.22%
+35.22%
1 Year
-9.43%
-9.43%

More News

Read More
Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
From ACCESSWIRE
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
From ACCESSWIRE
Adial Pharmaceuticals Enters Agreement to Acquire Purnovate, a Developer of Potential Therapies for Non-Opioid Pain Reduction and Treatment of Addiction
From ACCESSWIRE
Adial Pharmaceuticals CEO Weighs in on the Alcohol Pandemic and Drunk Driving Over the Holidays; FOX31 Denver's Shaul Turner Interviews Bill Stilley
From ACCESSWIRE
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured in Follow-up TV News Story
From ACCESSWIRE
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured on Multiple Television News Outlets
From ACCESSWIRE
Adial Pharmaceuticals Enters into Common Stock Purchase Agreement with Keystone Capital Partners to Support Strategic Opportunities and Future Growth Initiatives
From ACCESSWIRE
InvestorNewsBreaks – M Vest Unveils List of ‘Latest Companies in the Spotlight’
From InvestorBrandNetwork
Adial Pharmaceuticals Provides Update on its ONWARD(TM) Pivotal Phase 3 Trial of AD04 for Treatment of Alcohol Use Disorder
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.